PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $342,000 | -97.3% | 377,776 | -75.9% | 0.03% | -97.1% |
| Q4 2021 | $12,534,000 | +461.6% | 1,564,844 | +486.8% | 1.14% | +972.6% |
| Q3 2021 | $2,232,000 | +24.2% | 266,661 | 0.0% | 0.11% | +12.8% |
| Q2 2021 | $1,797,000 | -4.8% | 266,661 | -6.7% | 0.09% | -27.7% |
| Q1 2021 | $1,888,000 | +57.3% | 285,696 | 0.0% | 0.13% | +21.5% |
| Q4 2020 | $1,200,000 | -16.0% | 285,696 | -4.1% | 0.11% | -54.1% |
| Q3 2020 | $1,428,000 | -21.7% | 298,022 | -0.7% | 0.23% | -23.1% |
| Q2 2020 | $1,824,000 | -6.4% | 300,042 | -15.4% | 0.30% | -32.2% |
| Q1 2020 | $1,948,000 | +89.5% | 354,849 | +242.1% | 0.45% | +402.2% |
| Q4 2019 | $1,028,000 | – | 103,727 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |